Figure 4: The SRB assay on MRC-5 cell lines for evaluation of toxicity of THA in comparison to Paclitaxel
The viability of the MRC-5 cell lines treated with varying concentrations of THA and Paclitaxel was assessed at 24, 48 and 72 hours from treatment. The different concentrations at different time points were carried out in triplicate.